Manfredi M, Mergoni G, Goldoni M, Salvagni S, Merigo E, Meleti M, Vescovi P. A 5-year retrospective longitudinal study on the incidence and the risk factors of osteonecrosis of the jaws in patients treated with zoledronic acid for bone metastases from solid tumors. Med Oral Patol Oral Cir Bucal. 2017 May 1;22 (3):e342-8.

 

 

doi:10.4317/medoral.21728

http://dx.doi.org/doi:10.4317/medoral.21728

 

 

1. Ruggiero SL, Dodson TB, Assael LA, Landesberg R, Marx RE, Mehrotra B, et al. American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws--2009 update. J Oral Maxillofac Surg. 2009;67:2-12.

 

2. Rollason V, Laverrire A, MacDonald LCI, Walsh T, Tramr MR, Vogt-Ferrier NB. Interventions for treating bisphosphonate-related osteonecrosis of the jaw (BRONJ). Vogt-Ferrier NB, editor. Cochrane Database Syst Rev. Chichester, UK: John Wiley & Sons, Ltd; 2016;2:CD008455.

 

3. Khan AA, Morrison A, Hanley DA, Felsenberg D, McCauley LK, O'Ryan F, et al. Diagnosis and management of osteonecrosis of the jaw: a systematic review and international consensus. Journal of Bone and Mineral Research. 2015;30:3-23.
https://doi.org/10.1002/jbmr.2405

 

4. Ruggiero SL, Dodson TB, Fantasia J, Goodday R, Aghaloo T, Mehrotra B, et al. American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw--2014 update. Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons. 2014. pp. 1938-56.

 

5. Bisphosphonate-Related AO. Advisory Task Force on Bisphosphonate-Related Ostenonecrosis of the Jaws, American Association of Oral and Maxillofacial Surgeons. American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws. J Oral Maxillofac Surg. 2007;65:369-76.
https://doi.org/10.1016/j.joms.2006.11.003

 

6. Hinchy NV, Jayaprakash V, Rossitto RA, Anders PL, Korff KC, Canallatos P, et al. Osteonecrosis of the jaw - prevention and treatment strategies for oral health professionals. Oral Oncol. 2013;49:878-86.
https://doi.org/10.1016/j.oraloncology.2013.06.008

 

7. Marx RE. Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic. J Oral Maxillofac Surg. 2003;61:1115-7.
https://doi.org/10.1016/S0278-2391(03)00720-1

 

8. Vescovi P, Campisi G, Fusco V, Mergoni G, Manfredi M, Merigo E, et al. Surgery-triggered and non surgery-triggered Bisphosphonate-related Osteonecrosis of the Jaws (BRONJ): A retrospective analysis of 567 cases in an Italian multicenter study. Oral Oncol. 2011;47:191-4.
https://doi.org/10.1016/j.oraloncology.2010.11.007

 

9. Kyrgidis A, Vahtsevanos K, Koloutsos G, Andreadis C, Boukovinas I, Teleioudis Z, et al. Bisphosphonate-related osteonecrosis of the jaws: a case-control study of risk factors in breast cancer patients. J Clin Oncol. American Society of Clinical Oncology; 2008;26:4634-8.
https://doi.org/10.1200/JCO.2008.16.2768

 

10. L—pez-Jornet P, Camacho-Alonso F, Molina-Mi-ano F, G—mez-Garc’a F, Vicente-Ortega V. An experimental study of bisphosphonate-induced jaws osteonecrosis in Sprague-Dawley rats. J Oral Pathol Med. Blackwell Publishing Ltd; 2010;39:697-702.

 

11. Sonis ST, Watkins BA, Lyng GD, Lerman MA, Anderson KC. Bony changes in the jaws of rats treated with zoledronic acid and dexamethasone before dental extractions mimic bisphosphonate-related osteonecrosis in cancer patients. Oral Oncol. 2009;45:164-72.
https://doi.org/10.1016/j.oraloncology.2008.04.013

 

12. Amler MH, Johnson PL, Salman I. Histological and histochemical investigation of human alveolar socket healing in undisturbed extraction wounds. J Am Dent Assoc. 1960;61:32-44.
https://doi.org/10.14219/jada.archive.1960.0152

 

13. Steiner GG, Francis W, Burrell R, Kallet MP, Steiner DM, Macias R. The healing socket and socket regeneration. Compend Contin Educ Dent. 2008;29:114-6-118-120-4passim.

 

14. Kos M. Association of dental and periodontal status with bisphosphonate-related osteonecrosis of the jaws. A retrospective case controlled study. Arch Med Sci. 2014;10:117-23.
https://doi.org/10.5114/aoms.2014.40738

 

15. Aghaloo TL, Kang B, Sung EC, Shoff M, Ronconi M, Gotcher JE, et al. Periodontal disease and bisphosphonates induce osteonecrosis of the jaws in the rat. Journal of Bone and Mineral Research. 2011;26:1871-82.
https://doi.org/10.1002/jbmr.379

 

16. Aguirre JI, Akhter MP, Kimmel DB, Pingel JE, Williams A, Jorgensen M, et al. Oncologic doses of zoledronic acid induce osteonecrosis of the jaw-like lesions in rice rats (Oryzomys palustris) with periodontitis. Journal of Bone and Mineral Research. 2012;27:2130-43.
https://doi.org/10.1002/jbmr.1669

 

17. Li CL, Lu WW, Seneviratne CJ, Leung WK, Zwahlen RA, Zheng LW. Role of periodontal disease in bisphosphonate-related osteonecrosis of the jaws in ovariectomized rats. Clin Oral Implants Res. 2016;27:1-6.
https://doi.org/10.1111/clr.12502

 

18. Dimopoulos MA, Kastritis E, Bamia C, Melakopoulos I, Gika D, Roussou M, et al. Reduction of osteonecrosis of the jaw (ONJ) after implementation of preventive measures in patients with multiple myeloma treated with zoledronic acid. Ann Oncol. 2009;20:117-20.
https://doi.org/10.1093/annonc/mdn554

 

19. Ripamonti CI, Maniezzo M, Campa T, Fagnoni E, Brunelli C, Saibene G, et al. Decreased occurrence of osteonecrosis of the jaw after implementation of dental preventive measures in solid tumour patients with bone metastases treated with bisphosphonates. The experience of the National Cancer Institute of Milan. Ann Oncol. 2009;20:137-45.
https://doi.org/10.1093/annonc/mdn526